Significant Ownership of Bain Capital Life Sciences Opportunities IV, L.P.

Signature - Title
/s/ Andrew Hack - Andrew Hack, Partner of Bain Capital Life Sciences Investors, LLC
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Bain Capital Life Sciences Opportunities IV, L.P..

Notify me when Bain Capital Life Sciences Opportunities IV, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Bain Capital Life Sciences Opportunities IV, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OLMA OLEMA PHARMACEUTICALS, INC. Common Stock, $0.0001 par value per share 10% $244,963,774 +$47,926,339 8,508,641 +24% Bain Capital Life Sciences Opportunities IV, L.P. 31 Dec 2025

Schedules 13D/G Reported by Bain Capital Life Sciences Opportunities IV, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.